Stay updated with breaking news from Keith Berman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The former CEO of a biotechnology company who, at the start of the pandemic, falsely claimed to have invented a blood test capable of detecting Covid-19 in 15
Keith Berman, 70, of Westlake Village, California, pleaded guilty last December to securities fraud totaling around $28 million. The Justice Department said that from February through December 2020, Berman falsely claimed his Decision Diagnostics company had developed a 15-second test to detect COVID-19 in a finger prick sample of blood when, in reality, no such test existed. "Berman defrauded investors to profit from the pandemic," Nicole Argentieri, head of the Justice Department's criminal division, said in a statement.
Two Individuals Indicted for Operating $25 Million Crypto-Fraud - On December 11, a federal court in California unsealed a superseding indictment, which charged two men...
Former CEO and director of Decision Diagnostics Corp., Keith Berman, pleads guilty to securities fraud, wire fraud, and obstruction of an official proceeding.
Keith Berman, CEO and director of Decision Diagnostics Corp (DECN), a public medical device company, has pleaded guilty to securities fraud and wire fraud in connection with his scheme to defraud investors by making false and misleading ...